eli lilly tirzepatide fda approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - FDA approves Zepbound (tirzepatide) as

The biology is real, but the leap from a diabetes A1C number to a lifter gaining cleaner mass is a long one

These synergistic effects collectively provide a multidimensional therapeutic approach to attenuate disease progression and reduce cardiovascular complications

In clinical trials, participants taking semaglutide lost an average of 15% of their body weight, compared to only 2.6% for those on a placebo

Michie W, Beck JS, Mahaffy RG, Honein EF, Fowler GB

It quickly becomes a vicious cycle: I escape to deep focus to avoid overwhelm, but the more I do that, the more tasks pile up, making re-entry more overwhelming, which tempts me to go back under again